Pacific Biosciences of California, Inc. (PACB)

2.17 -0.20 (-8.44%) USD  |  NASDAQ  |  Dec 11, 16:00
2.19 +0.02 (+0.92%) After-Hours: 20:00
More

Pacific Biosciences of California Research and Development Expense (TTM): 99.79M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for PACB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Bruker Corp. 400.00M
ICU Medical, Inc. 88.76M
West Pharmaceutical Services, Inc. 71.00M
Clearpoint Neuro, Inc. 13.99M
Intellia Therapeutics, Inc. 407.11M